Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.280
-0.060-1.12%
Volume:446.12K
Turnover:2.39M
Market Cap:4.30B
PE:-22.57
High:5.550
Open:5.190
Low:5.190
Close:5.340
52wk High:9.560
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:1.25
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.234
ROE:-3.45%
ROA:-1.93%
PB:1.02
PE(LYR):-22.57
PS:3.94

Loading ...

Ocumension Therapeutics Enrolls First Patient in Dry Eye Drug Study

MT Newswires Live
·
Aug 31

China's Angelalign H1 Revenue Rises on Higher Clear Aligner Case Volume

Reuters
·
Aug 31

Israel's BioLineRx Q2 Net Loss Widens on Higher R&D Expenses

Reuters
·
Aug 31

OCUMENSION Initiates Phase III Trial of First-in-Class Dry Eye Drug OT-202 with First Patient Enrolled in China

Bulletin Express
·
Aug 31

OCUMENSION-B's Dry Eye Candidate OT-202 Commences Late-Stage Dosing in China

Stock News
·
Aug 31

Ocumension Completes First Patient Enrollment in Phase III China Trial of Dry Eye Drug OT-202

Reuters
·
Aug 31

China's Rainmed Medical H1 Revenue Rises, Net Loss Narrows

Reuters
·
Aug 31

Hong Kong's Lee's Pharmaceutical H1 Profit Jumps on Higher-Margin Product Sales

Reuters
·
Aug 31

China's HeartCare Medical H1 Revenue Surges on Stroke Segment Growth

Reuters
·
Aug 31

Ocumension Therapeutics (SEHK:1477) Stock Growth Story Runs Into Funding Risk

Simply Wall St.
·
Aug 30

OCUMENSION-B (01477) reports 57.5M yuan adjusted net loss for the first half, narrowing by 46.74% year-on-year

Stock News
·
Aug 29

China's Ocumension Therapeutics H1 Revenue Surges on Higher Ophthalmic Product Sales

Reuters
·
Aug 28

Ocumension Redirects HK$121.87 Million of Unused IPO and Placing Proceeds to Working Capital

Bulletin Express
·
Aug 28

Ocumension Therapeutics Shifts Hk$102.5 Million IPO Proceeds to Working Capital, General Corporate Uses

Reuters
·
Aug 28

Ocumension Therapeutics FY26 H1 Net Loss Narrows 25.2% to RMB 99.02 Million; Revenue Rises 44.1% to RMB 423.7 Million

Reuters
·
Aug 28

Ocumension Therapeutics - Board Does not Recommend Distribution of an Interim Dividend

THOMSON REUTERS
·
Aug 28

Ocumension Therapeutics - Adjusted Net Loss Narrowed by 46.7% to Rmb57.5 Mln for Six Months

THOMSON REUTERS
·
Aug 28

Zhongjing Wanxi Pharma Donates One Million Yuan to Quake-Hit Gyirong in Tibet

Deep News
·
Aug 28

AI-Driven Drug Discovery Reshaping Scientific Research Paradigms, Long-Term Focus on Continuously Evolving R&D Platforms

Stock News
·
Aug 27

Delisting Doesn't Halt Claims! Investors in Poly Pharm (300630) File Another Court Case

Deep News
·
Aug 26